文献速递神经与头颈病理细胞病理与分子病理

头颈部软骨肉瘤88例中IDH突变状态:颅底与面部骨骼及喉气管肿瘤的不同特征

IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract.
PubMed 文献 · Hum Pathol · 2018-10-05

该多中心系列分析88例头颈部软骨肉瘤的IDH1/IDH2基因突变频率,包括颅底30例、面部骨骼11例和喉气管软骨47例。总体64.9%的颅面软骨肉瘤存在IDH突变,颅底肿瘤突变率高达85.7%,面部骨骼肿瘤无IDH突变,喉气管软骨肉瘤突变率低(47例中11.8%)。IDH突变检测可能有助于颅底骨肿瘤的诊断,尤其在小活检样本中。

要点

  • 颅底软骨肉瘤IDH突变率高达85.7%,支持将其作为小活检的诊断工具。
  • 面部骨骼软骨肉瘤未检测到IDH突变,与颅底突变特征不同。
  • 喉气管软骨肉瘤IDH突变率低(47例中11.8%),提示不同肿瘤发生机制。

核心结论

  • 头颈部软骨肉瘤IDH突变频率因部位而异,颅底高突变、面部骨骼无突变、喉气管低突变。
  • IDH突变检测可能对颅底骨肿瘤的诊断有帮助,尤其适用于小活检样本。
  • 喉气管软骨肉瘤的低IDH突变率提示其肿瘤发生机制可能不同,需进一步研究。

研究设计与样本

  • 多中心系列分析88例头颈部软骨肉瘤,包括颅底30例、面部骨骼11例、喉气管软骨47例。
  • 评估IDH1和IDH2基因突变频率。

主要发现

  • 颅底和喉气管软骨肉瘤最常累及岩骨(43.3%)和环状软骨(31.9%)。
  • 总体64.9%的颅面软骨肉瘤存在IDH突变。
  • 颅底肿瘤IDH突变率为85.7%,面部骨骼肿瘤无IDH突变。
  • 喉气管软骨肉瘤中IDH突变率为11.8%(47例中)。

临床怎么用

  • 对颅底骨肿瘤的小活检样本,可评估IDH突变状态以辅助诊断。
  • 面部骨骼软骨肉瘤IDH突变阴性,诊断时需结合其他特征。
  • 喉气管软骨肉瘤IDH突变率低,不应依赖IDH突变检测作为主要诊断依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chondrosarcomas are rare primary malignant bone tumors that involve the head and neck region in 1% to 12% of cases. Central conventional chondrosarcoma is the most common subtype and is associated with isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene mutations in 50% to 60% of cases. We aimed to define the frequency of IDH1 and IDH2 gene mutations in a multicenter series of 88 cases of chondrosarcoma of the head and neck, including tumors involving the base of the skull (n = 30), the facial skeleton (n = 11), and the laryngeal and tracheal cartilages (n = 47). Petrous bone and cricoid cartilage were the most frequently involved sites for chondrosarcomas of the skull base and laryngotracheal tract (43.3% and 31.9%, respectively). Overall, 64.9% of craniofacial chondrosarcomas featured IDH mutations, with a high rate for skull base tumors (85.7%) but no IDH mutations in tumors of the facial skeleton. This different mutational profile could be related to the type of ossification, the bones of the base of the skull mainly resulting from endochondral ossification, and those of the face from intramembranous ossification. Conversely, mutation was infrequent in chondrosarcomas involving the laryngeal and tracheal cartilages (11.8% of 47 cases). Evaluation of IDH mutation status may be a useful diagnostic tool for bone tumors of the skull base, which are most often assessable with only small biopsy samples. The low rate of IDH mutations observed in laryngotracheal chondrosarcomas suggests a different mode of tumorigenesis needing further exploration.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Tallegas M, Miquelestorena-Standley É, Labit-Bouvier C, et al. IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract. Hum Pathol. 2018. PMID: 30296521. doi:10.1016/j.humpath.2018.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。